Global NT 3 Growth Factor Receptor Market Research Report 2024

Report ID: 1978059 | Published Date: Jan 2026 | No. of Page: 88 | Base Year: 2025 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 AZD-7451
        1.2.3 Larotrectinib
        1.2.4 DS-6051
        1.2.5 LM-22B10
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global NT 3 Growth Factor Receptor Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Breast Cancer
        1.3.3 Brain Cancer
        1.3.4 Solid Tumor
        1.3.5 Colon Cancer
        1.3.6 Fibrosarcoma
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global NT 3 Growth Factor Receptor Market Perspective (2017-2028)
    2.2 NT 3 Growth Factor Receptor Growth Trends by Region
        2.2.1 NT 3 Growth Factor Receptor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 NT 3 Growth Factor Receptor Historic Market Size by Region (2017-2022)
        2.2.3 NT 3 Growth Factor Receptor Forecasted Market Size by Region (2023-2028)
    2.3 NT 3 Growth Factor Receptor Market Dynamics
        2.3.1 NT 3 Growth Factor Receptor Industry Trends
        2.3.2 NT 3 Growth Factor Receptor Market Drivers
        2.3.3 NT 3 Growth Factor Receptor Market Challenges
        2.3.4 NT 3 Growth Factor Receptor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top NT 3 Growth Factor Receptor Players by Revenue
        3.1.1 Global Top NT 3 Growth Factor Receptor Players by Revenue (2017-2022)
        3.1.2 Global NT 3 Growth Factor Receptor Revenue Market Share by Players (2017-2022)
    3.2 Global NT 3 Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by NT 3 Growth Factor Receptor Revenue
    3.4 Global NT 3 Growth Factor Receptor Market Concentration Ratio
        3.4.1 Global NT 3 Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NT 3 Growth Factor Receptor Revenue in 2021
    3.5 NT 3 Growth Factor Receptor Key Players Head office and Area Served
    3.6 Key Players NT 3 Growth Factor Receptor Product Solution and Service
    3.7 Date of Enter into NT 3 Growth Factor Receptor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 NT 3 Growth Factor Receptor Breakdown Data by Type
    4.1 Global NT 3 Growth Factor Receptor Historic Market Size by Type (2017-2022)
    4.2 Global NT 3 Growth Factor Receptor Forecasted Market Size by Type (2023-2028)
5 NT 3 Growth Factor Receptor Breakdown Data by Application
    5.1 Global NT 3 Growth Factor Receptor Historic Market Size by Application (2017-2022)
    5.2 Global NT 3 Growth Factor Receptor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NT 3 Growth Factor Receptor Market Size (2017-2028)
    6.2 North America NT 3 Growth Factor Receptor Market Size by Country (2017-2022)
    6.3 North America NT 3 Growth Factor Receptor Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe NT 3 Growth Factor Receptor Market Size (2017-2028)
    7.2 Europe NT 3 Growth Factor Receptor Market Size by Country (2017-2022)
    7.3 Europe NT 3 Growth Factor Receptor Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific NT 3 Growth Factor Receptor Market Size (2017-2028)
    8.2 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Country (2017-2022)
    8.3 Asia-Pacific NT 3 Growth Factor Receptor Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America NT 3 Growth Factor Receptor Market Size (2017-2028)
    9.2 Latin America NT 3 Growth Factor Receptor Market Size by Country (2017-2022)
    9.3 Latin America NT 3 Growth Factor Receptor Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa NT 3 Growth Factor Receptor Market Size (2017-2028)
    10.2 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2017-2022)
    10.3 Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Array BioPharma Inc
        11.1.1 Array BioPharma Inc Company Detail
        11.1.2 Array BioPharma Inc Business Overview
        11.1.3 Array BioPharma Inc NT 3 Growth Factor Receptor Introduction
        11.1.4 Array BioPharma Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.1.5 Array BioPharma Inc Recent Development
    11.2 AstraZeneca Plc
        11.2.1 AstraZeneca Plc Company Detail
        11.2.2 AstraZeneca Plc Business Overview
        11.2.3 AstraZeneca Plc NT 3 Growth Factor Receptor Introduction
        11.2.4 AstraZeneca Plc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.2.5 AstraZeneca Plc Recent Development
    11.3 Daiichi Sankyo Company Ltd
        11.3.1 Daiichi Sankyo Company Ltd Company Detail
        11.3.2 Daiichi Sankyo Company Ltd Business Overview
        11.3.3 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Introduction
        11.3.4 Daiichi Sankyo Company Ltd Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.3.5 Daiichi Sankyo Company Ltd Recent Development
    11.4 Handok Inc
        11.4.1 Handok Inc Company Detail
        11.4.2 Handok Inc Business Overview
        11.4.3 Handok Inc NT 3 Growth Factor Receptor Introduction
        11.4.4 Handok Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.4.5 Handok Inc Recent Development
    11.5 Ignyta Inc
        11.5.1 Ignyta Inc Company Detail
        11.5.2 Ignyta Inc Business Overview
        11.5.3 Ignyta Inc NT 3 Growth Factor Receptor Introduction
        11.5.4 Ignyta Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.5.5 Ignyta Inc Recent Development
    11.6 Loxo Oncology Inc
        11.6.1 Loxo Oncology Inc Company Detail
        11.6.2 Loxo Oncology Inc Business Overview
        11.6.3 Loxo Oncology Inc NT 3 Growth Factor Receptor Introduction
        11.6.4 Loxo Oncology Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.6.5 Loxo Oncology Inc Recent Development
    11.7 Netris Pharma SAS
        11.7.1 Netris Pharma SAS Company Detail
        11.7.2 Netris Pharma SAS Business Overview
        11.7.3 Netris Pharma SAS NT 3 Growth Factor Receptor Introduction
        11.7.4 Netris Pharma SAS Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.7.5 Netris Pharma SAS Recent Development
    11.8 Plexxikon Inc
        11.8.1 Plexxikon Inc Company Detail
        11.8.2 Plexxikon Inc Business Overview
        11.8.3 Plexxikon Inc NT 3 Growth Factor Receptor Introduction
        11.8.4 Plexxikon Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022)
        11.8.5 Plexxikon Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global NT 3 Growth Factor Receptor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of AZD-7451
    Table 3. Key Players of Larotrectinib
    Table 4. Key Players of DS-6051
    Table 5. Key Players of LM-22B10
    Table 6. Key Players of Others
    Table 7. Global NT 3 Growth Factor Receptor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global NT 3 Growth Factor Receptor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global NT 3 Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global NT 3 Growth Factor Receptor Market Share by Region (2017-2022)
    Table 11. Global NT 3 Growth Factor Receptor Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global NT 3 Growth Factor Receptor Market Share by Region (2023-2028)
    Table 13. NT 3 Growth Factor Receptor Market Trends
    Table 14. NT 3 Growth Factor Receptor Market Drivers
    Table 15. NT 3 Growth Factor Receptor Market Challenges
    Table 16. NT 3 Growth Factor Receptor Market Restraints
    Table 17. Global NT 3 Growth Factor Receptor Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global NT 3 Growth Factor Receptor Market Share by Players (2017-2022)
    Table 19. Global Top NT 3 Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NT 3 Growth Factor Receptor as of 2021)
    Table 20. Ranking of Global Top NT 3 Growth Factor Receptor Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by NT 3 Growth Factor Receptor Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players NT 3 Growth Factor Receptor Product Solution and Service
    Table 24. Date of Enter into NT 3 Growth Factor Receptor Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global NT 3 Growth Factor Receptor Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2017-2022)
    Table 28. Global NT 3 Growth Factor Receptor Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global NT 3 Growth Factor Receptor Revenue Market Share by Type (2023-2028)
    Table 30. Global NT 3 Growth Factor Receptor Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global NT 3 Growth Factor Receptor Revenue Market Share by Application (2017-2022)
    Table 32. Global NT 3 Growth Factor Receptor Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global NT 3 Growth Factor Receptor Revenue Market Share by Application (2023-2028)
    Table 34. North America NT 3 Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America NT 3 Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe NT 3 Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe NT 3 Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific NT 3 Growth Factor Receptor Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America NT 3 Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America NT 3 Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa NT 3 Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Array BioPharma Inc Company Detail
    Table 45. Array BioPharma Inc Business Overview
    Table 46. Array BioPharma Inc NT 3 Growth Factor Receptor Product
    Table 47. Array BioPharma Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 48. Array BioPharma Inc Recent Development
    Table 49. AstraZeneca Plc Company Detail
    Table 50. AstraZeneca Plc Business Overview
    Table 51. AstraZeneca Plc NT 3 Growth Factor Receptor Product
    Table 52. AstraZeneca Plc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 53. AstraZeneca Plc Recent Development
    Table 54. Daiichi Sankyo Company Ltd Company Detail
    Table 55. Daiichi Sankyo Company Ltd Business Overview
    Table 56. Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Product
    Table 57. Daiichi Sankyo Company Ltd Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 58. Daiichi Sankyo Company Ltd Recent Development
    Table 59. Handok Inc Company Detail
    Table 60. Handok Inc Business Overview
    Table 61. Handok Inc NT 3 Growth Factor Receptor Product
    Table 62. Handok Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 63. Handok Inc Recent Development
    Table 64. Ignyta Inc Company Detail
    Table 65. Ignyta Inc Business Overview
    Table 66. Ignyta Inc NT 3 Growth Factor Receptor Product
    Table 67. Ignyta Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 68. Ignyta Inc Recent Development
    Table 69. Loxo Oncology Inc Company Detail
    Table 70. Loxo Oncology Inc Business Overview
    Table 71. Loxo Oncology Inc NT 3 Growth Factor Receptor Product
    Table 72. Loxo Oncology Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 73. Loxo Oncology Inc Recent Development
    Table 74. Netris Pharma SAS Company Detail
    Table 75. Netris Pharma SAS Business Overview
    Table 76. Netris Pharma SAS NT 3 Growth Factor Receptor Product
    Table 77. Netris Pharma SAS Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 78. Netris Pharma SAS Recent Development
    Table 79. Plexxikon Inc Company Detail
    Table 80. Plexxikon Inc Business Overview
    Table 81. Plexxikon Inc NT 3 Growth Factor Receptor Product
    Table 82. Plexxikon Inc Revenue in NT 3 Growth Factor Receptor Business (2017-2022) & (US$ Million)
    Table 83. Plexxikon Inc Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NT 3 Growth Factor Receptor Market Share by Type: 2021 VS 2028
    Figure 2. AZD-7451 Features
    Figure 3. Larotrectinib Features
    Figure 4. DS-6051 Features
    Figure 5. LM-22B10 Features
    Figure 6. Others Features
    Figure 7. Global NT 3 Growth Factor Receptor Market Share by Application in 2021 & 2028
    Figure 8. Breast Cancer Case Studies
    Figure 9. Brain Cancer Case Studies
    Figure 10. Solid Tumor Case Studies
    Figure 11. Colon Cancer Case Studies
    Figure 12. Fibrosarcoma Case Studies
    Figure 13. Others Case Studies
    Figure 14. NT 3 Growth Factor Receptor Report Years Considered
    Figure 15. Global NT 3 Growth Factor Receptor Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global NT 3 Growth Factor Receptor Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global NT 3 Growth Factor Receptor Market Share by Region: 2021 VS 2028
    Figure 18. Global NT 3 Growth Factor Receptor Market Share by Players in 2021
    Figure 19. Global Top NT 3 Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NT 3 Growth Factor Receptor as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by NT 3 Growth Factor Receptor Revenue in 2021
    Figure 21. North America NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America NT 3 Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 23. United States NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe NT 3 Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 27. Germany NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific NT 3 Growth Factor Receptor Market Share by Region (2017-2028)
    Figure 35. China NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America NT 3 Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 43. Mexico NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa NT 3 Growth Factor Receptor Market Share by Country (2017-2028)
    Figure 47. Turkey NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia NT 3 Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Array BioPharma Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 50. AstraZeneca Plc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 51. Daiichi Sankyo Company Ltd Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 52. Handok Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 53. Ignyta Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 54. Loxo Oncology Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 55. Netris Pharma SAS Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 56. Plexxikon Inc Revenue Growth Rate in NT 3 Growth Factor Receptor Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Array BioPharma Inc
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Netris Pharma SAS
Plexxikon Inc
Frequently Asked Questions
NT 3 Growth Factor Receptor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
NT 3 Growth Factor Receptor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
NT 3 Growth Factor Receptor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pol Polyprotein

Pol Polyprotein market is segmented by players, region (country), by Type and by Application. Pla ... Read More